2026 NPPES data Pediatric Endocrinology Physician NPI 1336567312 M.D.
Verify on CMS →

DANIEL TILDEN, M.D.

Pediatric Endocrinology Physician in KANSAS CITY, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
424
Medicare Part D claims · 90 beneficiaries · Pediatric Endocrinology Physician avg: 151
Generic prescribing
45%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.8902/100
▲ 9 pts above national avg 83.1 · [object Object]
Industry payments
$67.41
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

DANIEL TILDEN, M.D. reported a CMS MIPS final score of 91.8902/100 — above the 83.1 national average — and filed 424 Medicare Part D claims in 2023.

91.8902/100
MIPS score · +9 vs avg
424
Part D claims, 2023
45%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

DANIEL TILDEN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

92 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

DANIEL TILDEN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about DANIEL TILDEN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 04/07/2014

NPI 1336567312

Primary specialty

Pediatric Endocrinology Physician

Niche

1,457 US NPIs in this specialty

Medicare Part D claims

424 181% vs specialty avg

2023 prescription claims

Specialty avg: 151

MIPS final score

91.8902/100 8.790199999999999% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Kansas

How Pediatric Endocrinology Physician compares to other specialties among Kansas providers

Kansas providers

Pediatric Endocrinology Physician share within Kansas

1. Pediatric Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Endocrinology Physician share within Kansas

Medicare quality performance — MIPS

DANIEL TILDEN, M.D.'s 2023 MIPS final score plotted against the Pediatric Endocrinology Physician national average

High performer (top quartile)
MIPS Final Score
91.8902/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Pediatric Endocrinology Physician) — 91.8902/100 vs national avg 83.1

0%100%National avg83%91.9%
MIPS final score (Pediatric Endocrinology Physician) — 91.8902/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DANIEL TILDEN, M.D. is a Pediatric Endocrinology Physician provider practicing in KANSAS CITY, Kansas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1336567312. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DANIEL TILDEN, M.D. appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding M.D. credentials at 4000 CAMBRIDGE ST # MS 2024, KANSAS CITY, KS, 66160, with a listed phone of (913) 558-6022. NPI 1336567312 was issued on 04/07/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TILDEN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 424 prescription claims written by this provider, covering 90 Medicare beneficiaries and totaling roughly $250K in drug spend, split 55% brand-name and 45% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.8902/100 for the 2023 performance year (Quality 75.1734), compared with the national average of 83.1.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,457 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4000 CAMBRIDGE ST # MS 2024
KANSAS CITY, KS 66160

Provider Details

NPI 1336567312
Specialty Pediatric Endocrinology Physician
Credentials M.D.
Gender Male
NPI Issued 04/07/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.8902
Final Score
Avg: 83.1
75.1734
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where DANIEL TILDEN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KANSAS UNIVERSITY PHYSICIANS INC
GLADSTONE, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for DANIEL TILDEN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$67

Largest payer

SANOFI-AVENTIS U.S. LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

DANIEL TILDEN, M.D. — brand share 55.0%
Specialty average (est.)

55% brand-name claims vs 45% generic, on 424 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

424
Total Claims
$250K
Total Drug Cost
90
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
864
Total Day Supply
25,497
Brand vs Generic
55% brand / 45% generic
Brand Drug Cost
$239K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
65.9 years
Avg HCC Risk Score
2.36
Gender Split
57% female / 43% male
Age Distribution
<65: 26, 65-74: 51, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
45
Ozempic
Semaglutide
45
Jardiance
Empagliflozin
29
Synthroid
Levothyroxine Sodium
24
Metformin Hcl Er
Metformin Hcl
18
Trulicity
Dulaglutide
18
Hydrocortisone
15
Metformin Hcl
15
Lisinopril
14
Rosuvastatin Calcium
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Endocrinology Physician Overview

How DANIEL TILDEN, M.D. fits within the Pediatric Endocrinology Physician landscape nationally.

1,457
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

DANIEL TILDEN, M.D.'s 424 claims are above the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in Kansas

Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as TILDEN.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DANIEL TILDEN, M.D.'s specialty?
DANIEL TILDEN, M.D. specializes in Pediatric Endocrinology Physician and practices in KANSAS CITY, Kansas. Credentials: M.D..
How much does DANIEL TILDEN, M.D. prescribe under Medicare Part D?
In 2023, DANIEL TILDEN, M.D. wrote 424 Medicare Part D claims totaling $250K in drug costs for 90 beneficiaries.
What is DANIEL TILDEN, M.D.'s Medicare quality score?
DANIEL TILDEN, M.D. has a CMS MIPS Final Score of 91.8902/100 (Quality: 75.1734). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is DANIEL TILDEN, M.D. located?
DANIEL TILDEN, M.D. is located at 4000 CAMBRIDGE ST # MS 2024, KANSAS CITY, KS, 66160. Phone: (913) 558-6022.
What is DANIEL TILDEN, M.D.'s NPI number?
DANIEL TILDEN, M.D.'s National Provider Identifier (NPI) is 1336567312, issued on 04/07/2014.
Does DANIEL TILDEN, M.D. prescribe more brand-name or generic drugs?
DANIEL TILDEN, M.D.'s prescribing is 55% brand-name and 45% generic drugs by claim count, with $239K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,457 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does DANIEL TILDEN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, DANIEL TILDEN, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DANIEL TILDEN, M.D. accept Medicare?
DANIEL TILDEN, M.D. appears in CMS Medicare data with 424 Part D claims and 90 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DANIEL TILDEN, M.D.'s credentials?
DANIEL TILDEN, M.D.'s NPI is 1336567312 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology